Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 12, 2005, Pages 1670-1676

  Gallien, P ^b   Reymann, J M ^c   Amarenco, G ^d   Nicolas, B ^e   De Seze M ^f   Bellissant, Eric ^a,c  

^a UNIVERSITÉ DE RENNES 1   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d HÔPITAL ROTHSCHILD   (France)

^e Centre de Médecine Physique et Réadaptation   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; BOTULINUM TOXIN A; PLACEBO;

ADULT; ANORECTAL PRESSURE; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONDUCT DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETRUSOR DYSSYNERGIA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FEMUR FRACTURE; FOLLOW UP; HUMAN; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PYELONEPHRITIS; RADICULAR PAIN; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; STANDARD; STATISTICAL ANALYSIS; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE INCONTINENCE; URINE RETENTION; URODYNAMICS; UTERUS MYOMA;

BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMUSCULAR AGENTS; PLACEBOS; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC; URINATION DISORDERS; URODYNAMICS;

EID: 28144436446     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.045765     Document Type: Article

References (22)

1. Andersen JT, Bradley WE. The syndrome of detrusor-sphincter dyssynergia. J Urol 1976;116:493-5.
2. Blaivas JG, Barbalias GA. Detrusor-external sphincter dyssynergia in men with multiple sclerosis: an ominous urologic condition. J Urol 1984;131:91-4.
3. Barbalias GA, Nikiforidis G, Liatsikos EN. Vesicourethral dysfunction associated with multiple sclerosis: clinical and urodynamic perspectives. J Urol 1998;160:106-11.
4. Gallien P, Robineau S, Nicolas B, et al. Vesicourethral dysfunction and urodynamic findings in multiple sclerosis: a study of 149 cases. Arch Phys Med Rehabil 1998;79:255-7.
5. Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol 1999;161:743-57.
6. Leippold T, Reitz A, Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur Urol 2003;44:165-74.
7. Dykstra DD, Sidi AA, Scott AB, et al. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 1988;139:919-22.
8. Dykstra DD, Sidi AA. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil 1990;71:24-6.
9. Schurch B, Hauri D, Rodic B, et al. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 1996;155:1023-9.
10. Gallien P, Robineau S, Verin M, et al. Treatment of detrusor-sphincter dyssynergia by transperineal injection of botulinum toxin. Arch Phys Med Rehabil 1998;79:715-7.
11. Petit H, Wiart L, Gaujard E, et al. Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. Spinal Cord 1998;36:91-4.
12. Phelan MW, Franks M, Somogyi GT, et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 2001;165:1107-10.
13. de Sèze M, Petit H, Gallien P, et al. Botulinum A toxin and detrusor-sphincter dyssynergia: a double-blind lidocaïne-controlled study in 13 patients with spinal cord disease. Eur Urol 2002;42:56-62.
14. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
16. Kim YH, Goodman C, Omessi E, et al. The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis. J Urol 1998;159:972-6.
17. Whitehead J. The design and analysis of sequential clinical trials, revised 2nd ed. Chichester: Wiley, 1997.
18. Sébille V, Bellissant E. Sequential methods and group sequential designs for comparative clinical trials. Fundam Clin Pharmacol 2003;17:505-16.
19. Sébille V, Bellissant E. Comparison of the two-sided single triangular test to the double triangular test. Control Clin Trials 2001;22:503-14.
20. de Groat WC. A neurologic basis for the overactive bladder. Urology 1997;50(Suppl 6A):36-52.
21. Brading AF. A myogenic basis for the overactive bladder. Urology 1997;50(Suppl 6A):57-67.
22. Wanner MB, Rageth CJ, Zach GA. Pregnancy and autonomic hyperreflexia in patients with spinal cord lesions. Paraplegia 1987;25:482-90.